Bunt women called on to recognise their 'shakti'

Bengaluru, Jun 17: The Congress on Wednesday decided to field senior party leader B K Hariprasad and incumbent Naseer Ahmed as candidates for the coming legislative council polls in Karnataka.

"The Congress President Sonia Gandhi has approved the proposal for the candidature of B K Hariprasad and Naseer Ahmed as Congress candidates to contest the biennial elections to the Legislative Council of Karnataka to be elected by the MLAs," the AICC said in a release.

The election is necessitated as the term of seven MLCs- Naseer Ahmed, Jayamma, M C Venugopal, N S Bose Raju, H M Revanna (all Congress), T A Sharavana (JDS) and independent D U Mallikarjuna- will end June 30.

Polling will be held on June 29 to fill seven MLC berths, and June 18 is the last date for filing of nominations.

While the BJP is in a position to win four out of seven seats, the Congress can win two and the JD(S) one.

Twenty-eight valid votes of MLAs are required for each candidate to win.

Hariprasad’s candidature has been announced as his tenure in the Rajya Sabha is coming to end on June 25.

He has also served as general secretary of the party.

Naseer Ahmed, who is retiring as MLC on June 30, will be seeking another term.

According to state Congress president D K Shivakumar, more than 200 aspirants have sought tickets for the two seats that the party can win in the legislative council polls.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, May 6: More than a month after international flights have been barred, Karnataka government is preparing to quarantine all 10,823 of the state''s people poised to return home from overseas amid the Covid pandemic, an official said on Tuesday.

"The state has planned to quarantine all 10,823 passengers coming back to Karnataka. The quarantine guidelines framed as below would be applicable," said Health Commissioner Pankaj Kumar Pandey in a statement.

According to the Government of India, 10,823 Karnataka residents have been stranded abroad by April 30, comprising 4,408 tourists, 3,074 students, 2,784 migrants and professionals and 557 ship crew.

Out of the 10,823 people, the state government is expecting 6,100 to return early as the government has decided to allow Indians stuck abroad to return.

"All the passengers arriving at points of entry (airports and seaports) will be compulsorily screened for symptoms of Covid-19," said Pandey.

Point of entry screening will include self-reporting form verification, thermal screening, pulse oximeter reading, briefing with instructions, categorisation, stamping for some and downloading of Aarogya Setu, Quarantine Watch and Apthamitra apps.

Arriving passengers are also required to declare existing comorbidities such hypertension, diabetes, asthma or any lung disease, organ transplantations, cancer, tuberculosis and other ailments.

Passengers will be categorised into three groups: Category A (symptomatic on arrival), Category B (asymptomatic with co-morbidity or aged above 60 years) and Category C (rest of asymptomatic passengers).

Depending on the category into which the people fall, their quarantine place and time will be determined.

Category A arrivals will be subjected to institutional quarantine for a fortnight, Category B one week quarantine at a hotel or hostel, followed by another week at home, and Category C home quarantine for a fortnight.

Karnataka government is making elaborate arrangements and logistical means, deploying healthcare, police and several other departments into action to handle the huge influx of Kannadigas and state residents.

Pandey has issued a 21-page elaborate standard operating procedure (SOP) guidelines on how to face the international returnees.